Alleyne Cargill H, Barrow Daniel Louis, Oyesiku Nelson Mobolanle
Department of Neurosurgery, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
Surg Neurol. 2002 Jun;57(6):380-90; discussion 390. doi: 10.1016/s0090-3019(02)00705-x.
We describe a combined simultaneous approach to giant pituitary tumors and present a review of 10 patients undergoing this procedure with emphasis on patient selection, surgical technique, and results.
A retrospective review was performed of patients who had undergone a combined, simultaneous transsphenoidal and pterional craniotomy approach to a giant pituitary adenoma. Visual findings, endocrine presentation, and tumor type were compiled. Tumor stage and grade (Hardy classification) were based on MRI and intraoperative findings.
Gross total resection of tumor was achieved in 4 of 10 patients, near total (>90%) in 2 of 10, and subtotal (80-90%) in 4. At the time of follow-up (average, 29.7 months; range, 17-44 months), stereotactic radiosurgery had been performed in 2 patients. Of the 9 patients who presented with visual field loss, all had improvement at 1-month follow-up. At 6 months follow-up, resolution was complete in 5 patients and partial in 4. No patient had worsening of vision. Hypopituitarism persisted in all 5 patients who presented with it preoperatively.
The combined, simultaneous transsphenoidal and pterional approach described is indicated for a small subset of patients with giant (>3 cm) clinically nonfunctional pituitary tumors who meet the criteria of tumor configuration outlined where the surgeon cannot achieve complete resection by a single approach. We propose adding a new Hardy's scheme subtype, Stage B-a, to describe giant pituitary tumors with a dumbbell configuration. Combining both craniotomy and transsphenoidal approaches may achieve the goal of tumor resection with less need for multiple sequential operations.
我们描述一种针对巨大垂体瘤的联合同步手术方法,并对10例接受该手术的患者进行回顾,重点关注患者选择、手术技术和结果。
对接受联合同步经蝶窦和翼点开颅手术治疗巨大垂体腺瘤的患者进行回顾性研究。收集视力检查结果、内分泌表现和肿瘤类型。肿瘤分期和分级(Hardy分类)基于MRI和术中发现。
10例患者中4例实现肿瘤全切除,10例中有2例接近全切除(>90%),4例为次全切除(80 - 90%)。在随访时(平均29.7个月;范围17 - 44个月),2例患者接受了立体定向放射外科治疗。9例有视野缺损的患者在1个月随访时均有改善。在6个月随访时,5例患者视野缺损完全消失,4例部分改善。无患者视力恶化。术前存在垂体功能减退的5例患者垂体功能减退仍持续存在。
所描述的联合同步经蝶窦和翼点入路适用于一小部分巨大(>3 cm)临床无功能垂体瘤患者,这些患者符合所概述的肿瘤形态学标准,单一入路手术医生无法实现完全切除。我们建议增加一种新的Hardy分期亚型,即B - a期,以描述哑铃形巨大垂体瘤。联合开颅和经蝶窦入路可能实现肿瘤切除目标,减少多次序贯手术的需求。